Systematic review / meta-analysis / 2012
Evidence remains insufficient to confirm dietary interventions or PUFAs benefit multiple sclerosis.
Six randomized trials evaluated polyunsaturated fatty acids across 794 participants. Supplementation showed no meaningful impact on worsening disability after two years. Linoleic acid intake between 11 and 23 g/day conferred no benefit in 144 patients (RR 1.04, 95% CI 0.66 to 1.63), nor did 2.9 to 3.4 g/day in 65 progressive cases (RR 0.78, 95% CI 0.43 to 1.42). Omega-3 oils also showed no clear benefit in 292 relapsing-remitting participants (RR 0.82, 95% CI 0.65 to 1.03).
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 794 participants across 6 randomized controlled trials
- What was measured
- multiple sclerosis disease progression and relapse frequency
THE PAPER
Dietary interventions for multiple sclerosis.
Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Cochrane Database Syst Rev, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.